262 related articles for article (PubMed ID: 9720504)
21. Perforin and granzyme expression in cytotoxic T-cell lymphomas.
Yamashita Y; Yatabe Y; Tsuzuki T; Nakayama A; Hasegawa Y; Kojima H; Nagasawa T; Mori N
Mod Pathol; 1998 Apr; 11(4):313-23. PubMed ID: 9578080
[TBL] [Abstract][Full Text] [Related]
22. Molecular epidemiology of deletions and mutations of the latent membrane protein 1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders.
Smir BN; Hauke RJ; Bierman PJ; Gross TG; d'Amore F; Anderson JR; Greiner TC
Lab Invest; 1996 Oct; 75(4):575-88. PubMed ID: 8874388
[TBL] [Abstract][Full Text] [Related]
23. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
[TBL] [Abstract][Full Text] [Related]
24. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation.
Mori N; Yatabe Y; Oka K; Kinoshita T; Kobayashi T; Ono T; Asai J
Am J Pathol; 1996 Aug; 149(2):699-705. PubMed ID: 8702007
[TBL] [Abstract][Full Text] [Related]
25. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S
Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683
[TBL] [Abstract][Full Text] [Related]
26. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection.
Arber DA; Weiss LM; Albújar PF; Chen YY; Jaffe ES
Am J Surg Pathol; 1993 Apr; 17(4):392-9. PubMed ID: 8388175
[TBL] [Abstract][Full Text] [Related]
27. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
28. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus in primary gastrointestinal T cell lymphomas. Association with gluten-sensitive enteropathy, pathological features, and immunophenotype.
de Bruin PC; Jiwa NM; Oudejans JJ; Radaszkiewicz T; Meijer CJ
Am J Pathol; 1995 Apr; 146(4):861-7. PubMed ID: 7717453
[TBL] [Abstract][Full Text] [Related]
30. Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps.
Tao Q; Srivastava G; Dickens P; Ho FC
Am J Pathol; 1996 Oct; 149(4):1111-8. PubMed ID: 8863660
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas.
Kanavaros P; Briere J; Emile JF; Gaulard P
Leukemia; 1996 Jun; 10 Suppl 2():s84-7. PubMed ID: 8649060
[TBL] [Abstract][Full Text] [Related]
33. In situ detection of activated cytotoxic cells in follicular lymphomas.
Leger-Ravet MB; Devergne O; Peuchmaur M; Solal-Celigny P; Brousse N; Gaulard P; Galanaud P; Emilie D
Am J Pathol; 1994 Mar; 144(3):492-9. PubMed ID: 7510456
[TBL] [Abstract][Full Text] [Related]
34. Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan.
Wang LS; Chow KC; Wu YC; Li WY; Huang MH
Am J Gastroenterol; 1999 Oct; 94(10):2834-9. PubMed ID: 10520830
[TBL] [Abstract][Full Text] [Related]
35. [Clinical, phenotypic and genotypic aspects of nasal T-cell lymphoma and its causal association with Epstein-Barr virus].
Harabuchi Y; Imai S; Kataura A; Osato T
Nihon Rinsho; 1997 Feb; 55(2):394-9. PubMed ID: 9046830
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.
Tao Q; Ho FC; Loke SL; Srivastava G
Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236
[TBL] [Abstract][Full Text] [Related]
37. [High prevalence of the Epstein-Barr virus in a Mexican population with Hodgkin's disease].
Quintanilla-Martínez L; Gamboa-Domínguez A; Gámez-Ledesma I; Orozco-Estévez H; Angeles-Angeles A
Rev Invest Clin; 1994; 46(5):355-62. PubMed ID: 7839015
[TBL] [Abstract][Full Text] [Related]
38. Malignant lymphoma of the adrenal gland: its possible correlation with the Epstein-Barr virus.
Ohsawa M; Tomita Y; Hashimoto M; Yasunaga Y; Kanno H; Aozasa K
Mod Pathol; 1996 May; 9(5):534-43. PubMed ID: 8733769
[TBL] [Abstract][Full Text] [Related]
39. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
[TBL] [Abstract][Full Text] [Related]
40. [Epstein-Barr virus infection and expression of T-cell intracellular antigen-1 (TIA-1) in intestinal T-cell lymphoma].
Ren X; Liu W; Li G; Li F; Zhang S
Zhonghua Bing Li Xue Za Zhi; 1999 Oct; 28(5):348-51. PubMed ID: 11869547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
